Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.
about
Proteomics and peptidomics: moving toward precision medicine in urological malignanciesProteogenomic convergence for understanding cancer pathways and networks.Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.New mass-spectrometry-compatible degradable surfactant for tissue proteomicsEstablishment and characterization of a highly immunogenic human renal carcinoma cell linePhenotypic characterization of nanshi oral liquid alters metabolic signatures during disease preventionUnraveling Molecular Differences of Gastric Cancer by Label-Free Quantitative Proteomics Analysis.Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma.LC-MS/MS Analysis Unravels Deep Oxidation of Manganese Superoxide Dismutase in Kidney Cancer.The proteomic landscape of renal tumors.Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.Fast and Simple Protocols for Mass Spectrometry-Based Proteomics of Small Fresh Frozen Uterine Tissue Sections.Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.Proteome profiling of clear cell renal cell carcinoma in von Hippel-Lindau patients highlights upregulation of Xaa-Pro aminopeptidase-1, an anti-proliferative and anti-migratory exoprotease.Multiomics approach to identify novel biomarkers for dilated cardiomyopathy: Proteome and transcriptome analyses of 4C30 dilated cardiomyopathy mouse model.
P2860
Q26749401-B3F714EA-D49C-4B37-98F7-D486A9F46D97Q33792433-D668544B-E048-4B7A-932A-BFB5DC784DD7Q34450277-ACED8B58-BE8F-4E17-A266-61B81E0839F6Q35258659-08E7F317-D54D-4F2F-88EC-518FD525F36AQ36045807-E6E768F2-C03F-4E2A-AE30-B0E1321441F7Q36500840-B6920BFB-2AA5-409D-A6B2-91AC9DB9C13EQ36512558-5E21356E-397D-49D4-8897-128F6FDF4318Q37419277-7CBBA054-D722-4B0B-9A4D-22EEC59827C4Q37690790-8B4EF95E-DD58-454B-8C78-4E58536FFE9DQ38803559-A1F5FEE1-4C90-4831-BF64-A171B73EBAC7Q40160539-D2918AA2-48C1-44AE-8CAE-A9F0FC5DA516Q41338779-A3248B93-3F96-4FA8-85DC-72194FF65F21Q42380248-AF983D78-496F-42E8-8A5F-197F26445877Q45711994-DCE8BC90-54C8-441A-82FB-5E40F1CF2E83Q47097655-86E956D8-D25C-425E-956C-C1A1651AACC7Q50888538-A8145FCA-B635-4BA7-AEA5-49DFFF3E5626
P2860
Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantitative proteomics in res ...... arker discovery and profiling.
@en
Quantitative proteomics in res ...... arker discovery and profiling.
@nl
type
label
Quantitative proteomics in res ...... arker discovery and profiling.
@en
Quantitative proteomics in res ...... arker discovery and profiling.
@nl
prefLabel
Quantitative proteomics in res ...... arker discovery and profiling.
@en
Quantitative proteomics in res ...... arker discovery and profiling.
@nl
P2093
P2860
P356
P1476
Quantitative proteomics in res ...... marker discovery and profiling
@en
P2093
D J Lamont
J T-J Huang
P Zakikhani
P2860
P2888
P304
P356
10.1038/BJC.2014.24
P407
P577
2014-02-18T00:00:00Z